Research summary ·
Long-term metabolic consequences of in-utero gestational diabetes exposure and maternal treatment interventions: a systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This review pooled results from earlier studies on gestational diabetes. It asked how high blood sugar in pregnancy affects the child later. It also asked if treating the mother in pregnancy helps the child. The team used 9 trials and 7 studies that followed people. These studies came from 11 countries.
What they found
Children exposed to gestational diabetes had a higher body mass index. As adults, they were more likely to be overweight or obese. Fasting blood sugar showed no clear difference, and results varied a lot. In the trials, treating mothers showed a trend toward lower HbA1c in children. This trend was too weak to be sure. There were no clear effects on cholesterol, other blood fats or 2-hour sugar tests. No sign of publication bias was found.
What it means for patients
The authors say exposure in the womb brings metabolic risks into adulthood. They say treating the mother with diet, exercise or drugs may lower the child's risk. They advise caution, as study results differed a lot.
Why it is not certain yet
Results varied widely between studies, which weakens the pooled findings. The treatment effects in the trials were not clear. The authors say longer follow-up studies are needed to confirm lasting risk. Cohort studies show links, not proof of cause.
Source
Long-term metabolic consequences of in-utero gestational diabetes exposure and maternal treatment interventions: a systematic review and meta-analysis.
PubMed · PMID 42819227We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Gestational diabetes publications